High Outlier
Strength
3 mg/1
Manufacturer
Currax Pharmaceuticals LLCNDC
42847010330
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
2/16/2021
Active Ingredients
DOXEPIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA022036On Market Since
8/1/2010
Pharmacological Classes
Related Drugs
Same classification
No related drugs found.